TIAA CREF Investment Management’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2015
Q2 | – | Sell |
-79,147
| Closed | -$7.72M | – | 3246 |
|
2015
Q1 | $7.72M | Buy |
79,147
+3,947
| +5% | +$385K | 0.01% | 1329 |
|
2014
Q4 | $6.98M | Sell |
75,200
-7,827
| -9% | -$726K | ﹤0.01% | 1390 |
|
2014
Q3 | $5.71M | Sell |
83,027
-4,762
| -5% | -$328K | ﹤0.01% | 1510 |
|
2014
Q2 | $9.2M | Buy |
87,789
+6,858
| +8% | +$719K | 0.01% | 1218 |
|
2014
Q1 | $6.72M | Sell |
80,931
-1,390
| -2% | -$115K | ﹤0.01% | 1404 |
|
2013
Q4 | $5.33M | Buy |
82,321
+6,531
| +9% | +$423K | ﹤0.01% | 1598 |
|
2013
Q3 | $4.8M | Buy |
75,790
+537
| +0.7% | +$34K | ﹤0.01% | 1610 |
|
2013
Q2 | $3.16M | Buy |
+75,253
| New | +$3.16M | ﹤0.01% | 1862 |
|